Pharmaceutical Intermediates Market

Pharmaceutical Intermediates Market: Investments in Manufacturing to Ascend: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029

Ask The Analyst Customization Available Request Methodology
pharmaceutical intermediates market snapshot

Pharmaceutical Intermediates Market - Key Research Findings

  1. Global pharmaceutical intermediates market size in 2018 – Over US$ 26,800 Mn 

  1. The pharmaceutical intermediates market is envisaged to witness moderate expansion at an estimated 4.4% CAGR, over 2019-2029. 

  1. East Asia and North America are expected to remain high-growth regional markets for pharmaceutical intermediates. 

  • East Asia and North America are the leading regions in the pharmaceutical intermediates market, owing to the high number of the pharmaceutical raw material contract manufacturing companies in the region. 

  1. Increase in the number of mergers and acquisitions is expected to boost the pharmaceutical intermediates market. 

  • A majority of active operators in the pharmaceutical intermediates market are opting for strategic mergers and acquisitions.

  • The specialty contract manufacturing companies are being acquired by final drug formulation manufacturing companies to keep up with their requirement of the pharmaceutical intermediates and APIs (active pharmaceutical ingredients).

  • Pharmaceutical intermediates market is observing a growing trend of M&A, subsequently reducing demand- supply gap of the various APIs available on market. 

  1. Bulk drug intermediates segment are slated to remain an attractive segment in the global pharmaceutical intermediates market. 

  • Increasing demand for the chiral intermediates compared to achiral intermediates is the prominent driver, boosting pharmaceutical intermediates market revenues.

  • Soaring consumption of chiral active intermediates is attributed to superiority of chiral intermediates over achiral bulk drug intermediates.

 

pharmaceutical intermediates market

Top 3 Factors Shaping the Pharmaceutical Intermediates Market

  • Increasing Production of Final Drug Formulations

Increasing demand of various pharmaceutical intermediates and APIs owing to increasing production of the final drug formulation is expected to fuel the growth of the market. Globally, various manufacturing companies from the pharma and biopharma industries are focusing on improving their geographical product footprint.

Manufacturers are also focusing enhancing their product reach through various distribution channels in different countries, which is resulting in the massive hike in production capacity.

In January 2019, Fujifilm announced plans to boost the overall production capacity with the North Carolina facility expansion. During 2015-2017, there were more than 130 mergers and acquisitions in the pharma industry, prominently involving contract manufacturing organisations with operations in APIs and pharmaceutical intermediates.

  • Increasing Chronic Disease Prevalence

The rapidly increasing prevalence of chronic diseases and brisk expansion of geriatric population are among the key factors pushing the need for drug formulations for the management of chronic diseases, worldwide. For example, according to the World Health Organization (WHO), the prevalence of diabetes has surged from 108.0 million in 1980 to 422.0 million in 2014, and the number is rising rapidly. Moreover, WHO also states that the prevalence of chronic diseases will possibly increase by 57% by 2020, clearly indicating a possibility of a significant percentage of population to suffer from chronic diseases.

  • Increasing Manufacturing Investments

Leading pharmaceutical companies in pharmaceutical intermediates market have announced investments in manufacturing facilities to cater to the growing demand for high production capacity of pharmaceutical intermediates, reduced corporate tax rate (due to recent tax reforms in the US), and a firmer global footprint. The companies are also taking strong efforts in strengthening their presence in emerging markets.

For example, in July 2018, Pfizer announced its plan to invest around US$ 465.0 million to build a sterile injectable plant in Portage, Michigan. This step is a part of its announcement that it had made earlier in 2018 about its plans to invest around US$ 5.0 billion in a US-based capital project due to the recent corporate tax reforms in the country

Pharmaceutical Intermediates Market Structure Analysis

  • The global Pharmaceutical Intermediates market is categorized by small independent companies.

  • Besides production facility expansion, a majority of leading companies are focusing on the increasing their product portfolio offering by offering different types pharmaceutical intermediates.

  • The pharmaceutical intermediates market is a fragmented landscape and several manufacturing companies are based in the East Asia and South Asia regions owing to relatively lower production costs when compared to developed regions.

FMI has compiled a study on the pharmaceutical intermediates market, which offers an analysis and forecast of the Pharmaceutical Intermediates market in its publication titled ‘Pharmaceutical Intermediates Market: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029.’ This report on the Pharmaceutical intermediates market covers some of the key influencing factors on the demand and supply of Pharmaceutical Intermediates over the next several years. An in-depth review of the growth drivers, potential challenges, unique trends, and opportunities for the market participants is expected to equip readers to fully comprehend the overall landscape of the Pharmaceutical Intermediates market.

The report on the pharmaceutical intermediates market also covers an analysis of the key regions and countries of particular interest, which are estimated to become frontrunners or remain laggards over the forecast period. The report covers a historical analysis of the market from 2014 to 2018, and provides forecasts from 2019 to 2029 in terms of revenue in US$.

Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. There are different types of pharmaceutical intermediates and demand of each type of the pharmaceutical intermediates is high due to increasing pharmaceutical and biopharmaceutical production.

This report on the pharmaceutical intermediates market has been broken down into different chapters to enhance clarity and provide context. A brief executive summary at the beginning of the report consists of some of the key findings of the study on the pharmaceutical intermediates market, as well as market estimates and growth rates for important segments. The following chapter presents the definitions and scope of the study, as well as the coverage in terms of the way in which the pharmaceutical intermediates market is structured.

Subsequently, the chapter on the market background contains relevant economic indicators, such as per capita healthcare spending and increase in cancer cases, which elaborate the dynamics impacting the pharmaceutical intermediates market, as well as provides an explanation of the factors considered important to develop forecasts and estimates. The following chapters dive deep into the global pharmaceutical intermediates market, covering detailed information based on product type, application and end user. The next set of chapters provide a region-wise analysis and forecasts of the pharmaceutical intermediates market, which cover the vital aspects of the market in North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

A dashboard view of some of the key companies operating in the pharmaceutical intermediates market in terms of their offerings, regional presence, and other metrics is a precursor to the detailed profiles of these participants, which include their financial information, strategy overview, and products offered, SWOT analysis as well as analyst commentary. Some of the key players analyzed in the Pharmaceutical Intermediates market report include Chiracon GmbH, Aceto Corporation, Midas Pharma GmbH, BASF SE, Codexis, Inc., A.R. Life Sciences Private Limited, Dishman Group, ZCL Chemicals Ltd., Pfizer, Inc., Arkema Inc and Cambrex Corporation among others.

To develop the estimates for the pharmaceutical intermediates market, the global adoption/consumption of pharmaceutical intermediates was taken into account, which was followed by tracking key players and their product offering globally. This is then cross-referenced with the revenue generated from the sales of pharmaceutical intermediates for top companies globally.

Our team of analysts reviews and interpret data from a variety of sources. The data attributed to ‘FMI’ is derived by using a combination of various approaches, which are then consolidated, interpreted, and extrapolated by FMI analysts. Data is sourced from government statistics, trade associations, company annual reports, investor presentations, press articles & directories, technical publications, and online databases, which are cross-referenced with FMI’s reports and internal repository of data to filter and validate the collected information.

The intelligence gathered from desk research is supplemented by extensive interviews with selected key expert participants across the value chain not only to gain information specific to their role and operations, but also to obtain their perspective and insights of the issues impacting the pharmaceutical intermediates market.

Global Pharmaceutical Intermediates Market: Segmentation

Analysis by Product Type

  • Chemical Intermediates

  • Bulk Drug Intermediates

    • Chiral Intermediates

    • Achiral Intermediates

  • Custom Intermediates

Analysis by Category

  • Branded Drug Intermediates

  • Generic Drug Intermediates

Analysis by Application/Drug Type

  • Analgesics

  • Anti-Infective Drugs

  • Cardiovascular Drugs

  • Oral Antidiabetic Drugs

  • Antimicrobial Drugs

  • Others

Analysis by End User

  • Biotech & Pharma Companies

  • Research Laboratories

  • CMOs/CROs

Analysis by Region

  • North America

  • Latin America

  • Europe

  • East Asia

  • South Asia

  • Oceania

  • Middle East & Africa

Pharmaceutical Intermediates Market Reports - Table of Contents

1. Executive Summary

       1.1. Global Market Outlook

       1.2. Demand Side Trends

       1.3. Supply Side Trends

       1.4. Analysis and Recommendations

2. Market Overview

       2.1. Market Coverage / Taxonomy

       2.2. Market Definition / Scope / Limitations

3. Key Market Trends

       3.1. Key Trends Impacting the Market

       3.2. Product Innovation / Development Trends

4. Key Success Factors

       4.1. Product Adoption / Usage Analysis

       4.2. Product USPs / Features

       4.3. Strategic Promotional Activities, By Key Manufacturers

5. Global Pharmaceutical Intermediates Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

       5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

       5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

                5.2.1. Y-o-Y Growth Trend Analysis

                5.2.2. Absolute $ Opportunity Analysis

6. Market Background

       6.1. Macro-Economic Factors

                6.1.1. Increasing Healthcare R & D Spending

                6.1.2. Emergence of Academia as the Primary Organisation for Carrying Out Basic Research

       6.2. Forecast Factors - Relevance & Impact

                6.2.1. Prevalence of Chronic Diseases

                6.2.2. Increased Government Focus on Generic Drugs

                6.2.3. Growing Demand for Biologics and Specialty Drugs

                6.2.4. Production Capacity Growth

                6.2.5. Top Companies Historic Average Growth

       6.3. Market Dynamics

                6.3.1. Drivers

                6.3.2. Restraints

                6.3.3. Opportunity Analysis

7. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type 

       7.1. Introduction / Key Findings

       7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2013 - 2017

       7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2018 - 2018

                7.3.1. Chemical Intermediates

                7.3.2. Bulk Drug Intermediates

                            7.3.2.1. Chiral Intermediates

                            7.3.2.2. Achiral Intermediates

                7.3.3. Custom Intermediates

       7.4. Market Attractiveness Analysis By Product Type 

8. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Category

       8.1. Introduction / Key Findings

       8.2. Historical Market Size (US$ Mn) Analysis By Category, 2013 - 2017

       8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Category, 2018 - 2018

                8.3.1. Branded Drug Intermediates

                8.3.2. Generic Drug Intermediates 

       8.4. Market Attractiveness Analysis By Category

9. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Application

       9.1. Introduction / Key Findings

       9.2. Historical Market Size (US$ Mn) Analysis By Application, 2013 - 2017

       9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2018 - 2018

                9.3.1. Analgesics

                9.3.2. Anti-Infective Drugs

                9.3.3. Cardiovascular Drugs

                9.3.4. Oral Antidiabetic Drugs

                9.3.5. Antimicrobial Drugs

                9.3.6. Others 

       9.4. Market Attractiveness Analysis By Application

10. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by End User

       10.1. Introduction / Key Findings

       10.2. Historical Market Size (US$ Mn) Analysis By End User, 2013 - 2017

       10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2018 - 2018

                10.3.1. Biotech & Pharma Companies

                10.3.2. Research Laboratories

                10.3.3. CMOs/CROs

       10.4. Market Attractiveness Analysis By End User

11. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Region

       11.1. Introduction

       11.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2017

       11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2018 - 2018

                11.3.1. North America

                11.3.2. Latin America

                11.3.3. Europe

                11.3.4. Middle East and Africa (MEA)

                11.3.5. East Asia

                11.3.6. South Asia

                11.3.7. Oceania

       11.4. Market Attractiveness Analysis By Region

12. North America Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

       12.1. Introduction

       12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017

       12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

                12.3.1. By Country

                            12.3.1.1. U.S.

                            12.3.1.2. Canada

                12.3.2. By Product Type

                12.3.3. By Category

                12.3.4. By Application

                12.3.5. By End User

       12.4. Market Attractiveness Analysis

                12.4.1. By Country

                12.4.2. By Product Type

                12.4.3. By Category

                12.4.4. By Application

                12.4.5. By End User

       12.5. Key Market Participants - Intensity Mapping

       12.6. Drivers and Restraints - Impact Analysis

13. Latin America Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

       13.1. Introduction

       13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017

       13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

                13.3.1. By Country

                            13.3.1.1. Brazil

                            13.3.1.2. Mexico

                            13.3.1.3. Rest of Latin America

                13.3.2. By Product Type

                13.3.3. By Category

                13.3.4. By Application

                13.3.5. By End User

       13.4. Market Attractiveness Analysis

                13.4.1. By Country

                13.4.2. By Product Type

                13.4.3. By Category

                13.4.4. By Application

                13.4.5. By End User

       13.5. Key Market Participants - Intensity Mapping

       13.6. Drivers and Restraints - Impact Analysis

14. Europe Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

       14.1. Introduction

       14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017

       14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

                14.3.1. By Country

                            14.3.1.1. Germany

                            14.3.1.2. France

                            14.3.1.3. Italy

                            14.3.1.4. U.K.

                            14.3.1.5. BENELUX

                            14.3.1.6. Russia

                            14.3.1.7. Rest of Europe

                14.3.2. By Product Type

                14.3.3. By Category

                14.3.4. By Application

                14.3.5. By End User

       14.4. Market Attractiveness Analysis

                14.4.1. By Country

                14.4.2. By Product Type

                14.4.3. By Category

                14.4.4. By Application

                14.4.5. By End User

       14.5. Key Market Participants - Intensity Mapping

       14.6. Drivers and Restraints - Impact Analysis

15. South Asia Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

       15.1. Introduction

       15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017

       15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

                15.3.1. By Country

                            15.3.1.1. India

                            15.3.1.2. Thailand

                            15.3.1.3. Indonesia

                            15.3.1.4. Malaysia

                            15.3.1.5. Rest of South Asia

                15.3.2. By Product Type

                15.3.3. By Category

                15.3.4. By Application

                15.3.5. By End User

       15.4. Market Attractiveness Analysis

                15.4.1. By Country

                15.4.2. By Product Type

                15.4.3. By Category

                15.4.4. By Application

                15.4.5. By End User

       15.5. Key Market Participants - Intensity Mapping

       15.6. Drivers and Restraints - Impact Analysis

16. East Asia Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

       16.1. Introduction

       16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017

       16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

                16.3.1. By Country

                            16.3.1.1. China

                            16.3.1.2. Japan

                            16.3.1.3. South Korea

                16.3.2. By Product Type

                16.3.3. By Category

                16.3.4. By Application

                16.3.5. By End User

       16.4. Market Attractiveness Analysis

                16.4.1. By Country

                16.4.2. By Product Type

                16.4.3. By Category

                16.4.4. By Application

                16.4.5. By End User

       16.5. Key Market Participants - Intensity Mapping

       16.6. Drivers and Restraints - Impact Analysis

17. Oceania Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

       17.1. Introduction

       17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017

       17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

                17.3.1. By Country

                            17.3.1.1. Australia

                            17.3.1.2. New Zealand

                17.3.2. By Product Type

                17.3.3. By Category

                17.3.4. By Application

                17.3.5. By End User

       17.4. Market Attractiveness Analysis

                17.4.1. By Country

                17.4.2. By Product Type

                17.4.3. By Category

                17.4.4. By Application

                17.4.5. By End User

       17.5. Key Market Participants - Intensity Mapping

       17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

       18.1. Introduction

       18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017

       18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

                18.3.1. By Country

                            18.3.1.1. GCC Countries

                            18.3.1.2. South Africa

                            18.3.1.3. North Africa

                            18.3.1.4. Turkey

                            18.3.1.5. Rest of MEA

                18.3.2. By Product Type

                18.3.3. By Category

                18.3.4. By Application

                18.3.5. By End User

       18.4. Market Attractiveness Analysis

                18.4.1. By Country

                18.4.2. By Product Type

                18.4.3. By Category

                18.4.4. By Application

                18.4.5. By End User

       18.5. Key Market Participants - Intensity Mapping

       18.6. Drivers and Restraints - Impact Analysis

19. Emerging Countries Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

       19.1. Introduction

                19.1.1. Market Value Proportion Analysis, By Key Countries

                19.1.2. Global Vs. Country Growth Comparison

       19.2. China Pharmaceutical Intermediates Market Analysis

                19.2.1. Introduction

                19.2.2. PEST Analysis

                19.2.3. Market Value Proportion Analysis by Market Taxonomy

                19.2.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

                            19.2.4.1. By Product Type

                            19.2.4.2. By Category

                            19.2.4.3. By Application

                            19.2.4.4. By End User

                19.2.5. China Pharmaceutical Intermediates Market - Competition Landscape

                19.2.6. China - Trade Analysis

       19.3. India Pharmaceutical Intermediates Market Analysis

                19.3.1. Introduction

                19.3.2. PEST Analysis

                19.3.3. Market Value Proportion Analysis by Market Taxonomy

                19.3.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

                            19.3.4.1. By Product Type

                            19.3.4.2. By Category

                            19.3.4.3. By Application

                            19.3.4.4. By End User

                19.3.5. India Pharmaceutical Intermediates Market - Competition Landscape

       19.4. Russia Pharmaceutical Intermediates Market Analysis

                19.4.1. Introduction

                19.4.2. PEST Analysis

                19.4.3. Market Value Proportion Analysis by Market Taxonomy

                19.4.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

                            19.4.4.1. By Product Type

                            19.4.4.2. By Category

                            19.4.4.3. By Application

                            19.4.4.4. By End User

                19.4.5. Russia Pharmaceutical Intermediates Market - Competition Landscape

20. Market Structure Analysis

       20.1. Market Analysis by Tier of Companies (Pharmaceutical Intermediates)

       20.2. Market Concentration

       20.3. Market Share Analysis of Top Players

       20.4. Market Presence Analysis

                20.4.1. By Regional footprint of Players

                20.4.2. Product foot print by Players

                20.4.3. Channel Foot Print by Players

21. Competition Analysis

       21.1. Competition Dashboard

       21.2. Competition Benchmarking

       21.3. Competition Deep Dive 

                21.3.1. Chiracon GmbH

                            21.3.1.1. Company Overview

                            21.3.1.2. Analyst Commentary

                            21.3.1.3. Financial Analysis

                            21.3.1.4. Product Portfolio

                            21.3.1.5. Profitability by Market Segments (Product and Region)

                            21.3.1.6. Sales Footprint

                            21.3.1.7. Strategy Overview

                                           21.3.1.7.1. Marketing Strategy

                                           21.3.1.7.2. Product Strategy

                                           21.3.1.7.3. Channel Strategy

                21.3.2. Aceto Corporation

                21.3.3. Midas Pharma GmbH

                21.3.4. Codexis, Inc.

                21.3.5. Lianhetech

                21.3.6. BASF SE

                21.3.7. Vertellus Holdings LLC

                21.3.8. Sanofi Winthrop Industrie S.A.

                21.3.9. A.R. Life Sciences Private Limited

                21.3.10. Dishman Group

                21.3.11. Chemcon Specialty Chemical Pvt. Ltd.

                21.3.12. Dextra Laboratories Limited

                21.3.13. ZCL Chemicals Ltd.

                21.3.14. Easter Chemical Corporation

                21.3.15. Pfizer, Inc.

                21.3.16. Bristol-Myers Squibb Company

                21.3.17. Arkema Inc.

                21.3.18. Interchem

                21.3.19. Cambrex Corporation

22. Assumptions and Acronyms Used

23. Research Methodology

Pharmaceutical Intermediates Market Reports - List of Tables

List Of Tables

Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 03: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 04: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Table 05: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 06: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 07: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region

Table 08: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 09: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 10: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Table 11: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 12: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 13: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 14: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 15: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Table 16: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 17: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 18: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 19: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 20: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Table 21: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 22: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 23: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 24: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 25: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Table 26: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 27: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 28: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 29: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 30: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Table 31: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 32: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 33: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 34: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 35: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Table 36: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 37: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 38: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 39: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 40: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Table 41: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 42: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 43: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 44: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Table 45: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 46: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 47: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 48: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Table 49: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 50: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 51: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 52: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Table 53: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 54: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Pharmaceutical Intermediates Market Reports - List of Figures

List Of Figures

Figure 01: Global Pharmaceutical Intermediates Market Share, By Product Type  (2018)

Figure 02: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 03: Global Pharmaceutical Intermediates Market Share, By Category (2018)

Figure 04: Global Pharmaceutical Intermediates Market Share, By Application (2018)

Figure 05: Global Pharmaceutical Intermediates Market Share, By End User (2018)

Figure 06: Global Pharmaceutical Intermediates Market Share, By Region (2018)

Figure 07: Global Healthcare Expenditure in US$ Tn (2013–2020)

Figure 08: Global Pharmaceutical Intermediates Historical Market Size and Y-o-Y, 2014-2018

Figure 09: Global Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 10: Global Pharmaceutical Intermediates Market Absolute $ Opportunity, 2013–2028

Figure 11: : Global Pharmaceutical Intermediates Market Analysis by Product Type –2019 & 2029

Figure 12: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Figure 13: : Global Pharmaceutical Intermediates Market Analysis by Category –2019 & 2029

Figure 14: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029

Figure 15: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category

Figure 16: : Global Pharmaceutical Intermediates Market Analysis by Application –2019 & 2029

Figure 17: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029

Figure 18: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application

Figure 19: : Global Pharmaceutical Intermediates Market Analysis by End User –2019 & 2029

Figure 20: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029

Figure 21: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Figure 22: : Global Pharmaceutical Intermediates Market Analysis by Region –2019 & 2029

Figure 23: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Region, 2019 – 2029

Figure 24: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region

Figure 25: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018

Figure 26: North America Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029

Figure 27: : North America Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029

Figure 28: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029

Figure 29: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029

Figure 30: : North America Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029

Figure 31: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 32: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029

Figure 33: : North America Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029

Figure 34: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029

Figure 35: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029

Figure 36: : North America Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029

Figure 37: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029

Figure 38: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029

Figure 39: : North America Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029

Figure 40: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029

Figure 41: North America Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029

Figure 42: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018

Figure 43: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029

Figure 44: : Latin America Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029

Figure 45: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029

Figure 46: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029

Figure 47: : Latin America Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029

Figure 48: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 49: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029

Figure 50: : Latin America Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029

Figure 51: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029

Figure 52: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029

Figure 53: : Latin America Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029

Figure 54: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029

Figure 55: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029

Figure 56: : Latin America Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029

Figure 57: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029

Figure 58: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029

Figure 59: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018

Figure 60: Europe Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029

Figure 61: : Europe Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029

Figure 62: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029

Figure 63: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029

Figure 64: : Europe Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029

Figure 65: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 66: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029

Figure 67: : Europe Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029

Figure 68: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029

Figure 69: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029

Figure 70: : Europe Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029

Figure 71: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029

Figure 72: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029

Figure 73: : Europe Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029

Figure 74: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029

Figure 75: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029

Figure 76: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018

Figure 77: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029

Figure 78: : South Asia Pharmaceutical Intermediates Market Analysis by Country – 2019 & 2029

Figure 79: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029

Figure 80: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029

Figure 81: : South Asia Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029

Figure 82: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 83: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029

Figure 84: : South Asia Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029

Figure 85: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029

Figure 86: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029

Figure 87: : South Asia Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029

Figure 88: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029

Figure 89: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029

Figure 90: : South Asia Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029

Figure 91: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029

Figure 92: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029

Figure 93: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018

Figure 94: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029

Figure 95: : East Asia Pharmaceutical Intermediates Market Analysis by Country–2019 & 2029

Figure 96: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029

Figure 97: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029

Figure 98: : East Asia Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029

Figure 99: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 100: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029

Figure 101: : East Asia Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029

Figure 102: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029

Figure 103: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029

Figure 104: : East Asia Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029

Figure 105: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029

Figure 106: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029

Figure 107: : East Asia Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029

Figure 108: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029

Figure 109: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029

Figure 110: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018

Figure 111: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029

Figure 112: : Oceania Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029

Figure 113: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029

Figure 114: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029

Figure 115: : Oceania Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029

Figure 116: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 117: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029

Figure 118: : Oceania Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029

Figure 119: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029

Figure 120: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029

Figure 121: : Oceania Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029

Figure 122: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029

Figure 123: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029

Figure 124: : Oceania Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029

Figure 125: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029

Figure 126: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029

Figure 127: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018

Figure 128: MEA Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029

Figure 129: : MEA Pharmaceutical Intermediates Market Analysis by Country – 2019 & 2029

Figure 130: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029

Figure 131: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029

Figure 132: : MEA Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029

Figure 133: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 134: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029

Figure 135: : MEA Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029

Figure 136: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029

Figure 137: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029

Figure 138: : MEA Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029

Figure 139: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029

Figure 140: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029

Figure 141: : MEA Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029

Figure 142: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029

Figure 143: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029

Figure 144: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018

Figure 145: China Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029

Figure 146: : China Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029

Figure 147: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 148: China Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029

Figure 149: : China Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029

Figure 150: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029

Figure 151: China Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029

Figure 152: : China Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029

Figure 153: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029

Figure 154: China Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029

Figure 155: : China Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029

Figure 156: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029

Figure 157: China Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029

Figure 158: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018

Figure 159: India Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029

Figure 160: : India Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029

Figure 161: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 162: India Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029

Figure 163: : India Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029

Figure 164: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029

Figure 165: India Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029

Figure 166: : India Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029

Figure 167: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029

Figure 168: India Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029

Figure 169: : India Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029

Figure 170: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029

Figure 171: India Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029

Figure 172: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018

Figure 173: Russia Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029

Figure 174: : Russia Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029

Figure 175: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 176: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029

Figure 177: : Russia Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029

Figure 178: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029

Figure 179: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029

Figure 180: : Russia Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029

Figure 181: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029

Figure 182: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029

Figure 183: : Russia Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029

Figure 184: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029

Figure 185: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029